StemCell Therapy

BALTIMORE Vizuri Consumer Healthcare on Tuesday launched PainBloc24, a 24-hour over-the-counter topical pain reliever for arthritis joint pain. PainBloc24 has been clinically shown to help relieve pain with as little as one application per day, the company stated.

This is a great milestone for our company, and we know the 53 million people who suffer from chronic arthritis pain need a longer-lasting pain reliever," stated Jeremy Puttock, VP Vizuri Consumer Healthcare. "Were proud to bring a true breakthrough to the market and look forward to expanding distribution in the coming months.

The patent-pending NeuroMax technology in PainBloc24 delivers the maximum allowable OTC dose of its pain-blocking medicine, capsaicin, to turn off certain nerve fibers that send pain signals to the brain. In a clinical study, 60% of patients reported a reduction in arthritic knee pain for 24 hours following one-to-two daily applications of PainBloc24. In addition, patients who used the product for just seven days continued to experience relief from their arthritis pain for an additional three weeks after the last application.

PainBloc24 is available exclusively online and will be rolled out to food, drug and mass retailers this summer.

The rest is here:
Vizuri Consumer launches topical analgesic for 24-hour arthritis relief - Drug Store News

This entry was posted on April 19, 2017 at 2:46 pm and is filed under Arthritis. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |